☰

David W. Volk, Ph.D. - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Schizophrenia; structure, function and development of prefrontal cortex; effects of cannabis and psychotropic medications on neural circuitry
Tree Info Grants Similar researchers PubMed Report error

48/50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Jenkins AK, Lewis DA, Volk DW. Altered expression of microglial markers of phagocytosis in schizophrenia. Schizophrenia Research. 251: 22-29. PMID 36527956 DOI: 10.1016/j.schres.2022.12.005  0.684
2021 Roman KM, Jenkins AK, Lewis DA, Volk DW. Involvement of the nuclear factor-κB transcriptional complex in prefrontal cortex immune activation in bipolar disorder. Translational Psychiatry. 11: 40. PMID 33436571 DOI: 10.1038/s41398-020-01092-x  0.509
2019 Volk DW, Lewis DA. Insights Into the Pathophysiology of Endocannabinoid Signaling in Schizophrenia. Jama Psychiatry. PMID 31166594 DOI: 10.1001/Jamapsychiatry.2019.0844  0.646
2019 Jenkins A, Locker A, Volk D. F169. Increased mRNA Levels of Microglial Markers of Phagocytosis in Schizophrenia Biological Psychiatry. 85: S278-S279. DOI: 10.1016/J.Biopsych.2019.03.706  0.551
2018 Volk DW, Moroco AE, Roman KM, Edelson JR, Lewis DA. The Role of the Nuclear Factor-κB Transcriptional Complex in Cortical Immune Activation in Schizophrenia. Biological Psychiatry. PMID 30082065 DOI: 10.1016/J.Biopsych.2018.06.015  0.573
2018 Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research. PMID 29705007 DOI: 10.1016/J.Schres.2018.04.030  0.542
2016 Volk DW. Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia. Neurobiology of Disease. PMID 28007586 DOI: 10.1016/J.Nbd.2016.12.019  0.614
2016 Volk DW, Gonzalez-Burgos G, Lewis DA. l-Proline, GABA Synthesis and Gamma Oscillations in Schizophrenia. Trends in Neurosciences. PMID 27832914 DOI: 10.1016/J.Tins.2016.10.009  0.709
2016 Datta D, Arion D, Roman KM, Volk DW, Lewis DA. Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia. The American Journal of Psychiatry. appiajp201616020204. PMID 27523502 DOI: 10.1176/Appi.Ajp.2016.16020204  0.635
2016 Volk DW, Sampson AR, Zhang Y, Edelson JR, Lewis DA. Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders. Psychological Medicine. 1-12. PMID 27328999 DOI: 10.1017/S0033291716001446  0.673
2016 Volk DW, Edelson JR, Lewis DA. Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia. Schizophrenia Research. PMID 26972474 DOI: 10.1016/J.Schres.2016.03.001  0.722
2015 Kimoto S, Glausier JR, Fish KN, Volk DW, Bazmi HH, Arion D, Datta D, Lewis DA. Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia. Schizophrenia Bulletin. PMID 26424323 DOI: 10.1093/Schbul/Sbv139  0.825
2015 Chung DW, Volk DW, Arion D, Zhang Y, Sampson AR, Lewis DA. Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression. The American Journal of Psychiatry. appiajp201515020150. PMID 26337038 DOI: 10.1176/Appi.Ajp.2015.15020150  0.738
2015 Volk DW, Lewis DA. The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biological Psychiatry. PMID 26210060 DOI: 10.1016/J.Biopsych.2015.06.015  0.747
2015 Volk DW, Chitrapu A, Edelson JR, Roman KM, Moroco AE, Lewis DA. Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia. The American Journal of Psychiatry. appiajp201515010019. PMID 26133963 DOI: 10.1176/Appi.Ajp.2015.15010019  0.612
2015 Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA. Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. Schizophrenia Bulletin. 41: 180-91. PMID 24361861 DOI: 10.1093/Schbul/Sbt178  0.706
2014 Volk DW, Chitrapu A, Edelson JR, Lewis DA. Chemokine receptors and cortical interneuron dysfunction in schizophrenia. Schizophrenia Research. PMID 25464914 DOI: 10.1016/J.Schres.2014.10.031  0.803
2014 Volk DW, Eggan SM, Horti AG, Wong DF, Lewis DA. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophrenia Research. 159: 124-9. PMID 25107849 DOI: 10.1016/J.Schres.2014.07.017  0.838
2014 Volk DW, Lewis DA. Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia. Schizophrenia Bulletin. 40: 952-7. PMID 25053651 DOI: 10.1093/Schbul/Sbu111  0.745
2014 Volk DW, Edelson JR, Lewis DA. Cortical inhibitory neuron disturbances in schizophrenia: role of the ontogenetic transcription factor Lhx6. Schizophrenia Bulletin. 40: 1053-61. PMID 24837792 DOI: 10.1093/Schbul/Sbu068  0.769
2014 Siegel BI, Sengupta EJ, Edelson JR, Lewis DA, Volk DW. Elevated viral restriction factor levels in cortical blood vessels in schizophrenia. Biological Psychiatry. 76: 160-7. PMID 24209773 DOI: 10.1016/J.Biopsych.2013.09.019  0.774
2014 Volk DW, Lewis DA. Schizophrenia Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. 1293-1299. DOI: 10.1016/B978-0-12-410529-4.00105-4  0.635
2013 Volk DW, Lewis DA. Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience. 248: 154-64. PMID 23769891 DOI: 10.1016/J.Neuroscience.2013.06.008  0.758
2013 Volk DW, Siegel BI, Verrico CD, Lewis DA. Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophrenia Research. 147: 53-7. PMID 23561296 DOI: 10.1016/J.Schres.2013.02.038  0.807
2013 Curley AA, Eggan SM, Lazarus MS, Huang ZJ, Volk DW, Lewis DA. Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia. Neurobiology of Disease. 50: 179-86. PMID 23103418 DOI: 10.1016/J.Nbd.2012.10.018  0.838
2012 Volk DW, Matsubara T, Li S, Sengupta EJ, Georgiev D, Minabe Y, Sampson A, Hashimoto T, Lewis DA. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. The American Journal of Psychiatry. 169: 1082-1091. PMID 22983435 DOI: 10.1176/Appi.Ajp.2012.12030305  0.796
2012 Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends in Neurosciences. 35: 57-67. PMID 22154068 DOI: 10.1016/J.Tins.2011.10.004  0.826
2012 Eggan SM, Lazarus MS, Stoyak SR, Volk DW, Glausier JR, Huang ZJ, Lewis DA. Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. Biological Psychiatry. 71: 114-9. PMID 22036037 DOI: 10.1016/J.Biopsych.2011.09.014  0.823
2012 Volk DW, Radchenkova PV, Walker EM, Sengupta EJ, Lewis DA. Cortical opioid markers in schizophrenia and across postnatal development. Cerebral Cortex (New York, N.Y. : 1991). 22: 1215-23. PMID 21810780 DOI: 10.1093/Cercor/Bhr202  0.753
2011 Curley AA, Arion D, Volk DW, Asafu-Adjei JK, Sampson AR, Fish KN, Lewis DA. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. The American Journal of Psychiatry. 168: 921-9. PMID 21632647 DOI: 10.1176/Appi.Ajp.2011.11010052  0.86
2010 Volk DW, Lewis DA. Prefrontal cortical circuits in schizophrenia. Current Topics in Behavioral Neurosciences. 4: 485-508. PMID 21312410 DOI: 10.1007/7854_2010_44  0.712
2010 Volk DW, Eggan SM, Lewis DA. Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. The American Journal of Psychiatry. 167: 1489-98. PMID 20889653 DOI: 10.1176/Appi.Ajp.2010.10030318  0.86
2009 Maldonado-Avilés JG, Curley AA, Hashimoto T, Morrow AL, Ramsey AJ, O'Donnell P, Volk DW, Lewis DA. Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. The American Journal of Psychiatry. 166: 450-9. PMID 19289452 DOI: 10.1176/Appi.Ajp.2008.08101484  0.84
2008 Hashimoto T, Arion D, Unger T, Maldonado-Avilés JG, Morris HM, Volk DW, Mirnics K, Lewis DA. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Molecular Psychiatry. 13: 147-61. PMID 17471287 DOI: 10.1038/Sj.Mp.4002011  0.852
2005 Volk DW, Lewis DA. GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. Current Neuropharmacology. 3: 45-62. PMID 22545031 DOI: 10.2174/1570159052773396  0.697
2005 Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nature Reviews. Neuroscience. 6: 312-24. PMID 15803162 DOI: 10.1038/Nrn1648  0.738
2004 Tamminga C, Hashimoto T, Volk DW, Lewis DA. GABA neurons in the human prefrontal cortex. The American Journal of Psychiatry. 161: 1764. PMID 15465968 DOI: 10.1176/Ajp.161.10.1764  0.606
2004 Lewis DA, Volk DW, Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology. 174: 143-50. PMID 15205885 DOI: 10.1007/S00213-003-1673-X  0.723
2003 Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6315-26. PMID 12867516 DOI: 10.1523/Jneurosci.23-15-06315.2003  0.851
2003 Volk DW, Lewis DA. Effects of a mediodorsal thalamus lesion on prefrontal inhibitory circuitry: implications for schizophrenia. Biological Psychiatry. 53: 385-9. PMID 12614991 DOI: 10.1016/S0006-3223(02)01547-0  0.668
2003 Hashimoto T, Volk D, Eggan S, Pierri J, Sun Z, Sampson A, Lewis D. Altered gene expression in parvalbumin-containing GABA neurons in the prefrontal cortex of subjects with schizophrenia Schizophrenia Research. 60: 71. DOI: 10.1016/S0920-9964(03)80597-2  0.857
2002 Volk DW, Lewis DA. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiology & Behavior. 77: 501-5. PMID 12526990 DOI: 10.1016/S0031-9384(02)00936-8  0.742
2002 Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). 12: 1063-70. PMID 12217970 DOI: 10.1093/Cercor/12.10.1063  0.747
2001 Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: Decreased expression in a subset of neurons American Journal of Psychiatry. 158: 256-265. PMID 11156808 DOI: 10.1176/Appi.Ajp.158.2.256  0.732
2000 Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Archives of General Psychiatry. 57: 237-45. PMID 10711910 DOI: 10.1001/Archpsyc.57.3.237  0.767
2000 Volk D, Austin M, Pierri J, Lewis D. 51. Altered GABA transporter-1 mRNA expression in prefrontal cortical neurons in schizophrenia Biological Psychiatry. 47: S16. DOI: 10.1016/S0006-3223(00)00313-9  0.735
1999 Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biological Psychiatry. 46: 616-26. PMID 10472415 DOI: 10.1016/S0006-3223(99)00061-X  0.774
1996 Anderson SA, Volk DW, Lewis DA. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophrenia Research. 19: 111-9. PMID 8789909 DOI: 10.1016/0920-9964(96)88521-5  0.595
Low-probability matches (unlikely to be authored by this person)
2015 Kang SA, Hasan N, Mann AP, Zheng W, Zhao L, Morris L, Zhu W, Zhao YD, Suh KS, Dooley WC, Volk D, Gorenstein DG, Cristofanilli M, Rui H, Tanaka T. Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 1044-54. PMID 25815697 DOI: 10.1038/Mt.2015.45  0.017
2011 Mann AP, Bhavane RC, Somasunderam A, Montalvo-Ortiz BL, Ghaghada KB, Volk D, Nieves-Alicea R, Stephen Suh K, Ferrari M, Annapragada A, Gorenstein DG, Tanaka T. Thioaptamer conjugated liposomes for tumor vasculature targeting Oncotarget. 2: 298-304. PMID 21666286 DOI: 10.18632/Oncotarget.261  0.017
Hide low-probability matches.